Impact of metabolic syndrome among patients with and without diabetes mellitus on long-term outcomes after percutaneous coronary intervention

Hypertension Research

Volumn 31, Issue 2, 2008, Pages 235-241

  Kasai, Takatoshi ^a   Miyauchi, Katsumi ^a   Kurata, Takeshi ^a   Okazaki, Shinya ^a   Kajimoto, Kan ^a   Kubota, Naozumi ^a   Daida, Hiroyuki ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Coronary artery disease; Hypertension; Japanese; Obesity

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; NICORANDIL; NITRATE; WARFARIN;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORTALITY; OBESITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; POST HOC ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; SMOKING; SURVIVAL RATE;

ADULT; AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BODY MASS INDEX; CORONARY ARTERY DISEASE; DIABETES COMPLICATIONS; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROGNOSIS;

EID: 41549130280     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.235     Document Type: Article

References (20)

1. Takeuchi H, Saitoh S, Takagi S, et al: Metabolic syndrome and cardiac disease in Japanese men: applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program-Adult Treatment Panel III to Japanese Men - the Tanno and Sobetsu Study. Hypertens Res 2005; 28: 203-208.
2. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
3. Grundy SM, Cleeman JI, Daniels SR, et al: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung and Blood Institute scientific statement. Circulation 2005; 112: 2735-2752.
4. Malik S, Wong ND, Franklin SS, et al: Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004; 110: 1245-1250.
5. Isomaa B, Almgren P, Tuomi T, et al: Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-689.
6. Alexander CM, Landsman PB, Teutsch SM, Haffner SM: NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANESIII participants age 50 years and older. Diabetes 2003; 52: 1210-1214.
7. Rana IS, Monraats PS, Zwinderman AH, et al: GENDER study. Metabolic syndrome and risk of restenosis in patients undergoing percutaneous coronary intervention. Diabetes Care 2005; 28: 873-877.
8. Nigam A, Bourassa MG, Fortier A, Guertin MC, Tardif JC: The metabolic syndrome and its components and the long-term risk of death in patients with coronary heart disease. Am Heart J 2006; 151: 514-521.
9. Kasai T, Miyauchi K, Kurata T, et al: Prognostic value of the metabolic syndrome for long-term outcomes in patients undergoing percutaneous coronary intervention. Circ J 2006; 70: 1531-1537.
10. Examination Committee of Criteria for 'Obesity Disease' in Japan, Japan Society for the Study of Obesity: New criteria for 'obesity disease' in Japan. Circ J 2002; 66: 987-992.
11. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 2007; 30 (Suppl 1): S42-S47.
12. Alberti KG, Zimmet P, Shaw J: The metabolic syndrome - a new worldwide definition. Lancet 2005; 366: 1059-1062.
13. BARI Investigators: Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 1997; 96: 1761-1769.
14. Kurbaan AS, Bowker TJ, Ilsley CD, Sigwart U, Rickards AF, CABRI Investigators (Coronary Angioplasty versus Bypass Revascularization Investigation): Difference in the mortality of the CABRI diabetic and nondiabetic populations and its relation to coronary artery disease and the revascularization mode. Am J Cardiol 2001; 87: 947-950.
15. Barsness GW, Peterson ED, Ohman EM, et al: Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty. Circulation 1997; 96: 2551-2556.
16. Seidell JC, Kahn HS, Williamson DF, Lissner L, Valdez R: Report from a Centers for Disease Control and Prevention Workshop on use of adult anthropometry for public health and primary health care. Am J Clin Nutr 2001; 73: 123-126.
17. Ko GTC, Cban JC, Cockram CS, Woo J: Prediction of hypertension, diabetes, dyslipidaemia or albuminuria using simple anthropometric indexes in Hong Kong Chinese. Int J Obes Relat Metab Disord 1999; 23: 1136-1142.
18. Shiwaku K, Anuurad E, Enkhmaa B, et al: Overweight Japanese with body mass indexes of 23.0 to 24.9 have higher risks for obesity associated disorders: a comparison of Japanese and Mongolians. Int J Obes Relat Metab Disord 2004; 28: 152-158.
19. Wong ND, Sciammarella MG, Polk D, et al: The metabolic syndrome, diabetes, and subclinical atherosclerosis assessed by coronary calcium. J Am Coll Cardiol 2003; 41: 1547-1553.
20. Janssen I, Katzmarzyk PT, Ross R: Body mass index, waist circumference, and health risk. Arch Intern Med 2002; 162: 2074-2079.